{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:43:17Z","timestamp":1762674197695,"version":"3.37.3"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100001424","name":"American Liver Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001424","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001034","name":"Australian Liver Foundation","doi-asserted-by":"publisher","award":["88009"],"award-info":[{"award-number":["88009"]}],"id":[{"id":"10.13039\/501100001034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL116381"],"award-info":[{"award-number":["R01HL116381"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001861","name":"Forskningsr\u00e5det f\u00f6r Arbetsliv och Socialvetenskap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["K2012-70X-15428-08-3"],"award-info":[{"award-number":["K2012-70X-15428-08-3"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009780","name":"Region Sk\u00e5ne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.amjcard.2017.08.013","type":"journal-article","created":{"date-parts":[[2017,8,31]],"date-time":"2017-08-31T04:03:37Z","timestamp":1504152217000},"page":"1974-1979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment"],"prefix":"10.1016","volume":"120","author":[{"given":"Per","family":"W\u00e4ndell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6113-0472","authenticated-orcid":false,"given":"Axel C.","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin J.","family":"Holzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"\u00c4rnl\u00f6v","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7228-5015","authenticated-orcid":false,"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2017.08.013_bib0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijcard.2013.10.063","article-title":"Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: experience from the Stockholm health care system","volume":"170","author":"Forslund","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0015","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/joim.12114","article-title":"Atrial fibrillation prevalence revisited","volume":"274","author":"Friberg","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0020","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1161\/01.CIR.103.19.2365","article-title":"New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome","volume":"103","author":"Humphries","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0025","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.genm.2010.06.001","article-title":"Gender in atrial fibrillation: ten years later","volume":"7","author":"Michelena","year":"2010","journal-title":"Gend Med"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00228-010-0884-4","article-title":"Prevalence of hypothyroidism in Finland\u2014a nationwide prescription study","volume":"67","author":"Virta","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0035","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1089\/thy.2007.0033","article-title":"Treatment of hypothyroidism in elderly patients and in patients with cardiac disease","volume":"17","author":"Feldt-Rasmussen","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0040","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/archinte.1990.00390210063015","article-title":"Morbidity, mortality, and quality of life for patients treated with levothyroxine","volume":"150","author":"Petersen","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0045","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1210\/jc.2005-1833","article-title":"Mortality and vascular outcomes in patients treated for thyroid dysfunction","volume":"91","author":"Flynn","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0050","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/028134301750235358","article-title":"Five-year mortality in men and women with atrial fibrillation","volume":"19","author":"Wandell","year":"2001","journal-title":"Scand J Prim Health Care"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2011.07.066","article-title":"Total mortality among levothyroxine-treated women with atrial fibrillation in Swedish primary health care","volume":"152","author":"Wandell","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0060","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/bimj.200900310","article-title":"Laplace regression with censored data","volume":"52","author":"Bottai","year":"2010","journal-title":"Biom J"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0065","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","article-title":"Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts","volume":"126","author":"Gencer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1871530311313010003","article-title":"Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies","volume":"13","author":"Gencer","year":"2013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"suppl 2","key":"10.1016\/j.amjcard.2017.08.013_bib0075","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00059-014-4123-0","article-title":"Arrhythmia and thyroid dysfunction","volume":"40","author":"Marrakchi","year":"2015","journal-title":"Herz"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0080","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0085","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/EJE-12-0585","article-title":"How could we improve the increased cardiovascular mortality in patients with overt and subclinical hyperthyroidism?","volume":"167","author":"Biondi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0090","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/EJE-12-0627","article-title":"Mechanisms in endocrinology: heart failure and thyroid dysfunction","volume":"167","author":"Biondi","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0095","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0022-5223(99)70249-7","article-title":"A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery","volume":"117","author":"Mullis-Jansson","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0100","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/archinte.160.4.526","article-title":"The Colorado thyroid disease prevalence study","volume":"160","author":"Canaris","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0105","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","article-title":"Thyroid disease and lipids","volume":"12","author":"Duntas","year":"2002","journal-title":"Thyroid"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s002280050637","article-title":"Drug use in patients with atrial fibrillation in Swedish primary health care: a comparison 5 years apart","volume":"55","author":"Wandell","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0115","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/1471-2458-13-670","article-title":"High prevalence of diagnosis of diabetes, depression, anxiety, hypertension, asthma and COPD in the total population of Stockholm, Sweden\u2014a challenge for public health","volume":"13","author":"Carlsson","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0120","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1093\/eurjhf\/hft064","article-title":"The epidemiology of heart failure, based on data for 2.1 million inhabitants in Sweden","volume":"15","author":"Zarrinkoub","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0125","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1136\/jech.2003.008466","article-title":"Bias","volume":"58","author":"Delgado-Rodriguez","year":"2004","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.amjcard.2017.08.013_bib0130","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejheart.2004.12.007","article-title":"The validity of a diagnosis of heart failure in a hospital discharge register","volume":"7","author":"Ingelsson","year":"2005","journal-title":"Eur J Heart Fail"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917313838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914917313838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,22]],"date-time":"2022-06-22T07:19:18Z","timestamp":1655882358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914917313838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0002914917313838"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.08.013","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Mortality and Nonfatal Cardiovascular Events in Adults With Atrial Fibrillation With Versus Without Levothyroxine Treatment","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2017.08.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}